UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A/A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Arcadia Biosciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-37383 |
|
81-0571538 |
202 Cousteau Place, Suite 105 Davis, CA 95618 |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class to be |
|
Name of each exchange on which each |
Common Stock, par value $0.001 per share |
|
The NASDAQ Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
Securities Act registration statement file number to which this form relates: 333-202124
Securities to be registered pursuant to Section 12(g) of the Act: None
Item 1. Description of Registrants Securities to be Registered.
Arcadia Biosciences, Inc. (the Registrant) is incorporating by reference herein the description of its Common Stock, par value $0.001 (the Common Stock), that is contained under the heading Description of Capital Stock in its Registration Statement on Form S-1 (File No. 333-202124) filed on February 17, 2015, as amended (the Registration Statement).
The Registrant is also incorporating by reference herein the description of its Common Stock that is contained in any prospectus filed by us per Rule 424(b) under its Registration Statement.
Item 2. Exhibits.
Per the instructions, no exhibits are required to be listed. The Registrant neither has other classes of securities registered on The NASDAQ Stock Market LLC nor is the Common Stock to be registered per Section 12(g) of the Securities Exchange Act of 1934.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
ARCADIA BIOSCIENCES, INC. | |
|
| |
Date: May 14, 2015 |
| |
|
By: |
/s/ Eric J. Rey |
|
|
Eric J. Rey |
|
|
President and Chief Executive Officer |